Add this topic to your myFT Digest for news straight to your inbox
Seven broker-dealers including Citadel Securities face a challenge from a cancer vaccine company
Northwest Biotherapeutics claims Citadel Securities, Virtu and others drove down its share price
Biotech rebuffs attempt to put special agent on its board
International Edition